Introduction
Despite numerous attempts to develop new structural prototype in the search for more effective antimicrobials, benzothiazoles still remain as one of the most versatile class of compounds against microbes [1] [2] [3] [4] [5] [6] [7] and therefore, they are useful substructures for further molecular exploration. Benzothiazole derivatives have attracted continuing interest because of their various biological activities viz antitumor [8] [9] [10] [11] [12] [13] , antitubercular [14] , antimalarial [15] , anticonvulsant [16] , anthelmintic [17] , analgesic [18] , anti-inflammatory [19] and antidiabetic [20] . Recently benzothiazole derivatives have been evaluated as potential amyloidal-binding diagnostic agents in neurodegenerative disease [21, 22] and as selective fatty acid amide hydrolase inhibitors [23] . The above observations encouraged us to synthesize a novel series of benzothiazole derivatives and evaluated their antimicrobial activity.
Experimental

Instrumentation
All melting points were determined on an electrothermal Gallenkamp apparatus. The IR spectra were measured on a Pye-Unicam SP300 instrument in potassium bromide discs. The 1 H NMR spectra were recorded on Varian Mercury VXR-300 MHz spectrometer (300 or 400 MHz) and the chemical shifts  (ppm) down field from tetramethylsilane (TMS) as an internal standard. The mass spectra were recorded on a GCMS-Q1000-EX Shimadzu and GCMS 5988-A HP spectrometers, the ionizing voltage was 70 eV. Elemental analyses were carried out by the Microanalytical Center of Cairo University, Giza, Egypt. TLC was run on silica gel G coated plates and iodine vapor as visualizing agent.
Synthesis
Solvents were generally distilled and dried by standard literature procedures prior to use. 
Synthesis of 3-(5,6-dimethoxy-2-oxobenzo[d]thiazol-3(2H)-yl) propanohydrazide (3)
A mixture of compound 2 (3.11 g, 0.01 mol) hydrazine hydrate (98%) (2 mL, 0.04 mol) and 30 mL absolute ethanol was refluxed for 6 h. The reaction mixture was cooled; the formed precipitate was filtered, dried and recrystallized from acetic acid to give compound 3 (Scheme 1 
Synthesis of N-(3,4-dichloro-2,5-dioxo-2H-pyrrol-1 (5H)-yl)-3-(5,6-dimethoxy-2-oxobenzo[d]thiazol-3-(2H)-yl)propanamide (4)
A mixture of compound 3 (0.6 g, 0.002 mol) and dichloromaleic anhydride (0.33 g, 0.002 mol) in 5 mL acetic acid was refluxed for 8 h. The formed precipitate was filtered, dried and recrystallized from acetic acid to give compound 4 (Scheme 1 
Synthesis of 3-(5,6-dimethoxy-2-oxobenzothiazol-3-yl)-propionic acid (2-oxo-1,2-dihydro-indol-3-ylidene) hydrazide (5)
To a solution of compound 3 (0.6 g, 0.002 mol) in DMF (10 mL) was added isatin(0.3 g, 0.002 mol) refluxed for 4 h, left to cool then poured onto crushed ice. The product formed was filtered off and recrystallized from ethanol to give compound 5 (Scheme 1 
Synthesis of 3-(3-(3,5-dimethyl-1H-pyrazol-1-yl)-3-oxopropyl)-5,6-dimethoxybenzo[d]thiazol-2(3H)-one (6)
Refluxing a mixture of compound 3 (0.6 g, 0.002 mol), with acetyl acetone (2 mL, 0.002 mol) in 15 mL acetic acid for 8 h. The formed precipitate after cooling was filtered, dried and recrystallized from methanol:ethyl acetate 
Synthesis of ethyl 5-amino-1-(3-(5,6-dimethoxy-2-oxobenzo[d]thiazol-3(2H)-yl)propanoyl)-1H-pyrazole-4-carboxylate (7)
A mixture of compound 3 (0.6 g, 0.002 mol) and ethyl (ethoxymethylene) cyano-acetate (0.34 g, 0.002 mol) in absolute ethanol (20 mL) was heated under reflux for 8h. After cooling, the product was collected by filtration then recrystallized from ethanol to give compound 7 (Scheme 1 
Synthesis of ethyl N'-(3-(5,6-dimethoxy-2-oxobenzo[d] thiazol-3(2H)-yl)propanoyl)formohydrazonate (9)
A mixture of compound 3 (0.6 g, 0.002 mol) and triethylorthoformate (5 mL) was heated under reflux for 12 h. After cooling, the solvent was evaporated under reduced pressure and the solid product obtained was filtered off and recrystallized from ethanol to give compound 9 (Scheme 1 A mixture of compound 3 (0.6 g, 0.002 mol) and methyl isothiocyanate (0.15 g, 0.002 mol) in 10 mL DMF was refluxed for 6 h. After cooling pouring onto ice/cold water, acidified by hydrochloric acid, the formed precipitate was filtered dried and recrystallized from methanol to give compound 11 (Scheme 2 
Synthesis of 5,6-dimethoxy-3-(2-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)ethyl)benzo[d]thiazol-2(3H)-one (12)
A mixture of compound 3 (0.6 g, 0.002 mol) and carbon disulfide (6 mL) in pyridine (10 mL) and DMF (5 mL) was heated under reflux on water bath for 8 h. After cooling, the solvent was evaporated under reduced pressure and residue was triturated with an ice-water mixture and neutralized with diluted HCl. The solid precipitate formed was filtered off and recrystallized from ethanol to afford compound 12 (Scheme 2 
Synthesis of 3-(2-(4-amino-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)ethyl)-5,6-dimethoxybenzo[d]thiazol-2 (3H)-one (13)
A mixture of the oxadiazolinethione 12 (0.34 g, 0.001 mol) and hydrazine hydrate (3 mL) in absolute ethanol (20 mL) was heated under refluxed 6 h. After cooling, the solvent was removed in vacuum and the residue obtained was triturated with water. The solid product formed was filtered off and recrystallized from ethanol to afford compound 13 (Scheme 2 
Synthesis of 5,6-dimethoxy-3-(2-(5-((2-morpholino ethyl)thio)-1,3,4-oxadiazol-2-yl)ethyl)benzo[d]thiazol-2(3H)-one (14)
A mixture of the oxadiazolethione 12 (0.68 g, 0.002 mol), sodium acetate (0.38 g, 0.002 mol) and 4-(2-chloroethyl) morpholine hydrochloride (0.37 g, 0.002 mol) in ethanol (30 mL) was heated under reflux for 6 h. The solvent was evaporated and the residue was triturated with water. The solid product formed was collected by filtration and recrystallized from ethanol to give afford compound 14 (Scheme 2 
General procedure for preparation of Schiff's base compounds 15a-h
To a solution of compound 3 (0.6 g, 0.002 mol) in absolute ethanol (20 mL) containing glacial acetic acid (5 mL) was added different aromatic aldehydes (0.01 mol) the reaction mixture was refluxed for 5 h. Then cooled, poured onto crushed ice. The product was filtered off and recrystallized from acetic acid to give 15a-h (Scheme 3). 
3-(5,6-Dimethoxy-2-oxo-benzothiazol-3-yl)-propionic acid (4-fluoro-benzylidene)-hydrazide
General method for preparation of oxathiazolidin compound 16a-e
Thioglycolic acid (0.01 mol) was added to a well stirred solution of Schiff's bases (0.01 mol) 15a-d in dry benzene (50 mL). Then refluxed for 5 h and excess of solvent was evaporated under reduced pressure and the residue was washed by 2% NaHCO3, then treated with petroleum ether. The solid product was filtered off, washed with petroleum ether, and then recrystallized from methanol to give compound 16a-e, respectively (Scheme 3). (18), 468 (13), 461 (22), 435 (20), 420 (29), 408 (34), 303 (31), 276 (25), 212 (26), 195 (23), 132 (59), 91(100), 77 (54), 55 (22) 
3-(5, 6-Dimethoxy-2-oxo-benzothiazol-3-yl)-N-(2-(4-flurophenyl)-4-oxo-thiazolidin-3-yl)-propanamide
N-[2-(4-Chloro-phenyl)-4-oxo-thiazolidin-3-yl)-3-(5, 6-dimet hoxy-2-oxo-benzothiazol-3-yl)-propionamide
3-(5, 6-Dimethoxy-2-oxo-benzothiazol-3-yl)-N-[2-(1, 4-di phenyl-1H-pyrazol-3-yl)-4-oxo-thiazolidin-3-yl]-propionamide
3-(5, 6-Dimethoxy-2-oxo-benzothiazol-3-yl)-N-[2-(2-nitrophenyl)-4-oxo-thiazolidin-3-yl]-propionamide
3-(5, 6-Dimethoxy-2-oxo-benzothiazol-3-yl)-N-[2-(3-nitrophenyl)-4-oxo-thiazolidin-3-yl]-propionamide
Synthesis of 3-(5,6-dimethoxy-2-oxo-benzothiazol-3-yl)-propionicacid(4-{[3-5,6-dimethoxy-2-oxobenzothiazol-3-yl)-propionyl]-hydrazonomethyl}-benzlidene)-hydrazide (17)
To a solution of compound 3 (0.6 g, 0.002 mol) in absolute ethanol (20 mL) containing glacial acetic acid (5 mL) was added benzene 1,4 dicarbaldehyde (0.54 g, 0.004 mol). The reaction mixture was refluxed for 5 h then cooled, poured onto crushed ice. The product was filtered off and crystallized from acetic acid to give compound 17 (Scheme 3 
Biological evaluations
Preparation of microbial suspensions
Antimicrobial activities were tested out against highly pathogenic reference strains accused of causing food poisoning from food of animal origin. Two Gram positive bacteria (Methicillin resistance Staphylococcus aureus (MRSA), Staphylococcus aureus NCINB 50080), two Gram negative bacteria (Escherichia coli O157ATCC 700728, Escherichia coli ATCC 11775) and one mycotic strain (Candida albicans ATCC10231) were selected as model organisms. Agar well diffusion (qualitative method) and minimum inhibitory concentration (MIC) (quantitative method) were used in this study. Wherein a suspension ofbacterial and mycotic strains were freshly prepared by inoculating fresh stock culture from each strain into separate broth tubes, each containing 7 mL of Muller Hinton Broth for bacterial strains and Sabaroud Dextrose broth for mycotic strain. The inoculated tubes were incubated at 37 and 28 °C for 24 h, respectively. Serial dilutions were carried out for each strain, dilution matching with 0.5 Mc-Farland (about 1×10 8 cells/mL), was selected for screening of antimicrobial activities. Ciprofloxacin 100 µg/mL and fluconazole 100 µg/mL were used as reference drugs (Oxoid), DMSO was used as control negative.
Determination of antimicrobial activity by agar well diffusion method
Muller Hinton and Sabaroud Dextrose agar plates were prepared [24, 25] . Bacterial and fungal strains matching with 0.5 Mc-Farland were spread onto the surface of the agar plates using sterile cotton swabs. For evaluation of antibacterial activities, wells were formed in the agar plates using pasture pipette and each well was filled with 50 µL of the compound dissolved in DMSO (300 µg of the tested compound dissolved in 1 mL DMSO), others were saturated with 50 µL ciprofloxacin (100 µg/mL) and others 50 µL DMSO as control negative. The same method was used for evaluation of antimycotic activities using fluconazole (100 µg/mL). Then inoculated agar plates and left for 1 h at 25 °C to allow a period of preincubation diffusion in order to minimize the effects of variation in time between the applications of different solutions. The plates were re-incubated at 37 °C and 28 °C for 24 h for bacterial and mycotic isolates, respectively. After incubation, plates were observed for antimicrobial activities, zone of inhibition were measured in mm using a ruler. The experiment was carried out in duplicate and the mean of the zone of inhibition was tabulated in Table 1 .
Determination of Minimum Inhibitory concentration (MIC)
Microtiter dilution plate quantitative method, i.e. the minimum inhibitory concentration (MIC) was used for evaluation of the antimicrobial activity of tested compounds. Determination of MIC of extract against tested strains was achieved using 96-well sterile micro plates. The first well contain the concentrated form of the tested compound used in the agar disk diffusion method (300 µg of the tested compound dissolved in 1 mL DMSO), then two fold serial dilutions was carried out for the tested compounds, reference drugs (ciprofloxacin and fluconazole) and DMSO, Then wells were inoculated with 100 µL of tested isolates (0.5 Mc-Farland, about 1×10 8 cells/mL) and incubated at 37-28 °C for 24 h for bacterial and fungal strains respectively. After incubation, plates were examined visually for bacterial or fungal growth precipitation. The experiment was repeated three times. The lowest concentration that showed complete hindrance of growth was taken as MIC.
Results and discussion
Chemistry
The key intermediate 3 was prepared by condensation of 5,6-dimethoxy-3H-benzothiazol-2-one (1) with ethylbromo propanoate to give ethyl 3-(5,6-dimethoxy-2-oxobenzo[d] thiazol-3(2H)-yl)propanoate (2) which was condensed with hydrazine hydrate (98%) in ethanol to give 3-(5,6-dimethoxy-2-oxobenzo[d]thiazol-3(2H)-yl) propanehydrazide (3) which is very useful starting material for the synthesis of all target compounds. The structures of compounds 2 and 3 were established on the basis of elemental analyses and spectral data. The reaction of compound 3 with dichloromaleic anhydride in acetic acid gave the amide compound 4 [26] . The mass spectrum of compound 4 showed the molecular ion peak M + at m/e 445. Simple reaction of hydrazide (3) with isatin in absolute ethanol containing a catalytic amount of glacial acetic acid gave compound 5 [27] . 1 H NMR spectrum of compound 5 showed the appearance of two singlet signals representing the proton of two NH groups near δ 11.22 and 12.49 ppm. Also, cyclization of compound 3 with acetylacetone afforded the corresponding pyrazole derivative 6 [28] . Structure of compound 6 was assigned to the reaction product on the basis of 1 H NMR spectrum, which revealed the absence of amino group and exhibited signals corresponding to two methyl groups. Furthermore, hydrazide 3 reacted with ethyl (ethoxymethylene)cyanoacetate in boiling ethanol to give the corresponding pyrazole derivative 7. The 1 H NMR spectrum of compound 7 displayed the characteristic triplet and quartet signals at δ 1.21 and 3.78 ppm, respectively assigned to the ethyl protons and D2O exchangeable singlet signal at δ 9.97 ppm due to NH2 protons. When compound 3 was allowed to react with triethyl orthoformate, the product was not the expected oxadiazole derivative 8 but it was identified as the methylenepropano hydrazide derivative 9 (Scheme 1) [29] .
Moreover, fusion of hydrazide 3 with ammonium thiocyanate gave the corresponding mercaptotriazole derivative 10. Furthermore, treatment of hydrazide 3 with methyl isothiocyanate gave 4-methylthiosemicarbazide derivative 11. The structure of compound 11 was confirmed by its IR spectrum, which displayed absorption bands at 3329 cm -1 for NH, 1650 cm -1 due to C=O and 1249 cm -1 corresponding to C=S stretch vibrations. The reaction of compound 3 with carbon disulfide in boiling pyridine and DMF gave the corresponding oxadiazole derivative 12 which was converted to the aminotriazole derivative 13 through condensation with hydrazine hydrate. Also alkylation of compound 12 with 4-(2-chloroethyl) morpholine hydrochloride in boiling ethanol in the presence of fused sodium acetate gave the corresponding morpholine derivative 14 (Scheme 2).
To get a new series of expected biologically active Schiff's bases 15a-h, it was of interest to condense compound 3 with different aromatic and/or heterocyclic aldehydes in ethanol containing few drops of glacial acetic acid (Scheme 3).
The structures of compounds 15a-h were established on the basis of elemental analyses and spectral data. The IR spectrum of compound 15a showed an absorption peak at 1606 cm -1 due to C=N stretching vibrations, its 1 HNMR spectrum displayed a singlet signal at δ 7.87 ppm attributed to -N=CH proton and a multiple at δ 7.05-7.54 ppm for Ar-H protons and its mass spectra showed the molecular ion peak M + at m/e 403 corresponding to the molecular formula C19H18FN3O4S. Also the reactivity of compounds 15a-e towards other reagents has been investigated to obtain new biologically active heterocyclic systems. Thus, the reaction of Schiff's bases 15a-e with thioglycolic acid in dry benzene gave the thiazolidinones 16a-e (Scheme 3) [30] . The cyclic structures were readily determined on the basis of 1 H NMR spectra, which clearly indicated the absence of the ylidenic proton and the appearance of new singlet signals at δ 5.60-5.90 ppm assigned to azomethine proton. It was of interest to react hydrazide 3 with benzene-1,4-dicarbaldehyde to afford the bis-benzothiazole 17. 1 H NMR spectrum of the compound confirmed the proposed structure by revealing an increase in the integration of the aromatic protons relative to hydrazide 3.
Biological activities
All the newly synthesized compounds 3-15h were screened for their antimicrobial activity determined by agar diffusion method [24, 25] for determination of the preliminary antibacterial and antifungal activity and the results were recorded for each tested compound as the average diameter of inhibition zones (IZ) of bacterial or fungal growth around the discs in mm (Table 1 ). In addition, the minimum inhibitory concentrations (MIC) were recorded for compounds that showed promising growth inhibition using the two-fold serial dilution method [31, 32] . The MIC (µg/mL) values against the tested bacterial and fungal isolates were recorded in Table 2 .
The potentiality of the synthesized compounds as antimicrobials was appraised for their antimicrobial studies against two strains of Gram positive bacteria (S. aureus NCINB 50080, MRSA), and two strains of Gram negative bacteria (E. coli ATCC 11775, E. coli O157ATCC 700728) using ciprofloxacin as a standard drug (100 μg/mL). They were also evaluated for their in vitro antifungal activity against the mycotic strain (C. albicans ATCC10231) using fluconazole as a standard antifungal drug (100 μg/mL).
According to the data of Table 1 and 2, it is clear that six compounds 15a, 3, 4, 10, 15f and 15h were found the most potent, they showed moderate activity against E. coli ATCC 11775 and S. Aureus NCINB 50080 strains compared to the reference standard ciprofloxacin (Figure 1) . DMSO was also taken in a control experiment which showed no effect in the experiment. The Schiff base 15a containing 4-fluro substituted phenyl ring was found the most potent against E. coli ATCC 11775 and S. Aureus NCINB 50080 strains with zone of inhibition 15 and 14 mm, respectively, and MIC equals 25 µg/mL. It was more potent than the parent hydrazide 3 (zone of inhibition 13 and 12 mm and MIC equals 50 and 100 µg/mL, respectively) and the two Schiff's bases 15f and 15h containing trimethoxy substituted phenyl and 5-meethylfuryl functionalities, respect-tively (zone of inhibition 12 mm and MIC equals 100 µg/mL). Furthermore, the dichloropyrrol dione compound 4 and the mercaptotriazole derivative 10 displayed equal antibacterial activity (zone of inhibition 12 mm, 11 and 12 mm, respectively and MIC equals 100 µg/mL).
Moreover, four compounds; mercaptotriazole 10 and its oxadiazole bioisoster 12 (zone of inhibition 13 mm, 11mm and 12 mm, and MIC equals 50, 100 µg/mL and 100 µg/mL, respectively) as well as the hydrazone 9 (zone of inhibition 12 mm,10 mm and MIC equals 100 µg/mL) and the 4-fluoro substituted thiazolidinone 16a (zone of inhibition 12 mm, 11 mm and MIC equals 100 µg/mL) were the most potent antibacterial compounds tested against Gram negative bacterial strains; E. coli ATCC 11775 and E. coli O157 ATCC 700728 (Figure 2) . It is obvious from the analysis activity results that the 4-flourophenyl substituted compounds have considerable activity against both tested Gram positive (S. Aureus NCINB 50080) and Gram negative (E. coli ATCC 11775 and E. coli O157 ATCC 700728) bacterial strains. This observation is supported by the antibacterial activity shown by compounds 15a and 16a. On the other hand, all the tested compounds showed negative hindrance activities against tested Methicillin Resistance Staph aureus.
Further, these compounds 3-15h were also screened for their antifungal activity against C. Albicans ATCC1023. Fluconazole was taken as a standard drug throughout the experiment. Only compound 3 showed hindrance effect against C. Albicans ATCC10231 with zone of inhibition 11 mm and MIC equals 100 µg/mL.
Conclusion
In conclusion, we report the synthesis of new derivatives of pyrrole, indolylidene, pyrazoles, mercaptotriazole, oxadiazole, triazole and oxothiazolidine incorporated with the benzothiazole unit via reaction of 3-(5,6-dimethoxy-2-oxobenzo[d] thiazol-3(2H)-yl)propanohydrazide (3) with different reagents. The structures of the newly synthesized compounds were established on the basis of spectral data (IR, 1 H NMR, 13 C NMR, Mass) and elemental analyses. Also some of the newly synthesized compounds were evaluated for antimicrobial activity and the results showed that some compounds showed good activity against the tested microorganisms.
